Discussion record
- Score
- 57
- Comments
- 32
- Read
- 34
Full-thread reading
The summary has not passed its automated publication checks.
The summary gate never changes the score, comment count, story metadata, or retained-history figures above.
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Posted by 1659447091 on 2026-08-07 · text.npr.org